BRAF and neoplasm: But a significantly better mOS (high tumor infiltration CD68+ macrophages vs. low tumor infiltration CD68+ macrophages cases, 26 vs. 15 months, P = 0.002) was observed in BRAF wide-type mCRC with higher tumor infiltration CD68+ macrophages [88].